Login / Signup

Strengthening the reporting of harms of all interventions in clinical trials.

Christina Abdel ShaheedChristopher G MaherAnn-Mason FurmageTammy HoffmannAndrew J McLachlan
Published in: The Medical journal of Australia (2022)
Keyphrases
  • clinical trial
  • physical activity
  • adverse drug
  • phase ii
  • open label
  • phase iii
  • emergency department
  • randomized controlled trial